ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1958

Diagnostic Value of Ultrasonography-Derived Signs in Giant Cell Arteritis: Literature Review and Meta-Analysis

Fanny BUSQUET1, Léa Rouxel2, Thomas Barnetche3 and Thierry Schaeverbeke4, 1intern of hospital, BORDEAUX, France, 2intern of hospital, Bordeaux, France, 3PHD, bordeaux, France, 4department head, Bordeaux, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: giant cell arteritis, Temporal arteritis, ultrasonography and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Giant Cell Arteritis (GCA) is the most common form of systemic inflammatory vasculitis in elderly people, with prevalence still increasing, and for which there is no consensual diagnostic method. Indeed the relevance of temporal artery wall edema is still a matter of debate, despite two previous meta-analyses by Karassa et al. in 2005 and Arida et al. in 2010.  We re-evaluated the diagnostic value of the ultrasonography-derived signs of the temporal artery for GCA diagnosis.

Methods:

We selected prospective studies concerning patients with suspected GCA published up to February 2015 in the Pubmed, Cochrane library and Embase databases. Studies using ultrasound biomicroscopy were excluded.

Diagnostic performances were determined for the following ultrasonographic signs: halo (unilateral or bilateral), blood flow abnormalities (stenosis and/or occlusions) and unilateral halo associated with BFA. The gold standard used was either the American College of Rheumatology (ACR) 1990 criteria or temporal artery biopsy. Weighed sensitivity and specificity for each sign were assessed, as well as statistical heterogeneity. P-values less than 0.05 were considered as significant.

Results:

We included 16 studies involving 964 patients suspected of GCA. Among these patients, 448 patients were diagnosed by ACR criteria (41% of which were ACR+) and 764 by temporal biopsy (48% of which showed temporal arteritis).

Ultrasound was performed in all patients. The halo sign was found in 29% of cases among which 76% had a positive biopsy. Among patients ACR+, the unilateral halo sign had an overall sensitivity of 68.2% (95% CI 0.58-0.79) and specificity of 93.2% (95 % CI  0.88-0.99). The same sign did not improve when associated to BFA: overall sensitivity of 64.2% (95% CI 0.17-1.17) and specificity of 93.4% (95% CI 0.85-1). The bilateral halo sign among ACR+ patients had an overall sensitivity of 58.2% (95% CI 0.19-0.97). The latter’s specificity was about 100% (95% CI 0.92-1) but was only estimated in one study. Among patients with a positive biopsy,  the unilateral halo sign had an overall sensitivity of 82.4% (95% CI 0.77-0.88) and specificity of 86.8% (95% CI  0.82-0.92) with the same absence of improvement as in the previous group when associated to BFA. The bilateral halo sign achieved an overall sensitivity of 51.7% (95% CI 0.42-0.62) and specificity of 82.4%(95% CI 0.57-1). It is to be noticed that between-study heterogeneity was very significant for all these calculations (I2 > 40%). A positive biopsy was found in 58 patients among the 439 without the halo sign (13% of false-negative). 80.7% of ACR+ patients had a positive biopsy and 19.3% had a normal biopsy.

Conclusion:

Among all ultrasonography-derived signs, the unilateral halo sign may be sufficient in GCA diagnosis. However, this meta-analysis did not confirm the infallibility of these signs, in particular in case of an absence of ultrasonographic signs. This last situation should be explored in further studies.


Disclosure: F. BUSQUET, None; L. Rouxel, None; T. Barnetche, None; T. Schaeverbeke, None.

To cite this abstract in AMA style:

BUSQUET F, Rouxel L, Barnetche T, Schaeverbeke T. Diagnostic Value of Ultrasonography-Derived Signs in Giant Cell Arteritis: Literature Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/diagnostic-value-of-ultrasonography-derived-signs-in-giant-cell-arteritis-literature-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-value-of-ultrasonography-derived-signs-in-giant-cell-arteritis-literature-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology